Maintenance therapy with Rituxan (rituximab) is superior to standard care with azathioprine for preventing disease relapses in patients…
Alice Melão
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melão
Avacopan (CCX168) can effectively improve remission rates, kidney function, and overall quality of life of patients with anti-neutrophil cytoplasmic…
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis can result in inflammation of the appendix — commonly known as appendicitis — without…
Measuring the levels of activin A protein in the urine can help clinicians identify patients who have renal problems…
ANCA-associated vasculitis (AAV) with childhood onset often affects multiple organs, showing symptoms at diagnosis in the ear, nose, and…
People with ANCA-associated vasculitis (AAV) are much more likely to develop a type of skin cancer called squamous cell…
The U.S. Food and Drug Administration (FDA) has approved Pfizer‘s Ruxience (rituximab-pvvr), a biosimilar to Rituxan…
Major infections are the main cause of poor long-term outcomes and death in patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis,…
People who live in the U.S. and have eosinophilic granulomatosis with polyangiitis (EGPA) now can be treated with…
High blood levels of a signaling molecule called interleukin-21, or IL-21, may identify patients with active ANCA-associated vasculitis (AVV),…